ENP69: Biosimilar Insulin
In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Endocrine News Podcast?
This episode is 16 minutes long.
When was this Endocrine News Podcast episode published?
This episode was published on April 12, 2023.
Can I download this Endocrine News Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.